Chengan Xu, Shouhao Wang, Di Meng, Mingshan Wang, Rong Yan, Yining Dai. Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways. // BMC Gastroenterology. – 2025. – DOI: 10.1186/s12876-025-03632-5. – URL: https://doi.org/10.1186/s12876-025-03632-5
Chengan Xu, Shouhao Wang, Di Meng, Mingshan Wang, Rong Yan, & Yining Dai (2025). Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways. BMC Gastroenterology. https://doi.org/10.1186/s12876-025-03632-5
Chengan Xu, et al. “Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways.” BMC Gastroenterology, 2025. doi:10.1186/s12876-025-03632-5.
@article{Xu2025,
title = {Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways},
author = {Xu, Chengan and Wang, Shouhao and Meng, Di and Wang, Mingshan and Yan, Rong and Dai, Yining},
journal = {BMC Gastroenterology},
year = {2025},
doi = {10.1186/s12876-025-03632-5},
url = {https://doi.org/10.1186/s12876-025-03632-5}
}